Notwithstanding various setbacks, several MDM2 inhibitors have now progressed into late-phase medical improvement. New strategies have also been made to reinforce the efficacy of MDM2 inhibitors and to mitigate their on-target toxicity. Within this review, we summarize the development and issues in the development of the MDM2 specific therapy. Keep https://dorsomorphin22098.blogacep.com/36926281/not-known-factual-statements-about-abbv-744